Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Long-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Recruiting

    3 1 1 1
    Austria Bulgaria Czechia Denmark France Germany +8
  • EIK1005 Alone and with Pembrolizumab for Advanced Solid Tumors in Patients with MSI-H or dMMR Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Denmark Finland France Germany +5
  • Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

    Recruiting

    3 1 1
    Investigated Drugs:
    Bulgaria Croatia Germany Hungary Poland Portugal +1
  • Pumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia Finland France +10
  • QTX-2101 and Arsenic Trioxide in Adult Patients With Acute Promyelocytic Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Poland Romania Spain
  • Obrixtamig, Carboplatin, and Etoposide for First-Line Treatment of Advanced Extrapulmonary Neuroendocrine Carcinoma in DLL3-Positive Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia Denmark Finland France +8
  • Lerodalcibep for Heterozygous Familial Hypercholesterolemia in Children and Adolescents 6 to 17 Years Old

    Recruiting

    3 1
    Investigated Drugs:
    Norway
  • Open-Label Extension Study of ATH434-DP2 in Patients with Multiple System Atrophy

    Recruiting

    2 1 1
    Investigated Diseases:
    France
  • Ifinatamab deruxtecan in Patients With Advanced Esophageal Squamous Cell Carcinoma

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Norway
  • RO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes

    Recruiting

    3 1
    Czechia France Germany Hungary Italy Poland +2